Correlation Between TG Therapeutics and Partner Communications

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Partner Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Partner Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and Partner Communications, you can compare the effects of market volatilities on TG Therapeutics and Partner Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Partner Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Partner Communications.

Diversification Opportunities for TG Therapeutics and Partner Communications

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between TGTX and Partner is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Partner Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Partner Communications and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Partner Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Partner Communications has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Partner Communications go up and down completely randomly.

Pair Corralation between TG Therapeutics and Partner Communications

If you would invest  2,325  in TG Therapeutics on September 22, 2024 and sell it today you would earn a total of  895.00  from holding TG Therapeutics or generate 38.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy1.56%
ValuesDaily Returns

TG Therapeutics  vs.  Partner Communications

 Performance 
       Timeline  
TG Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Partner Communications 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Partner Communications has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Partner Communications is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

TG Therapeutics and Partner Communications Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TG Therapeutics and Partner Communications

The main advantage of trading using opposite TG Therapeutics and Partner Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Partner Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Partner Communications will offset losses from the drop in Partner Communications' long position.
The idea behind TG Therapeutics and Partner Communications pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data